Ruti Aga: Six Years, One Forged Prescription, and the Empty Page in Marathon's Medical Governance

In March this year a half marathon was run in China and Ruti Aga won it. The race has no name in the Athletics Integrity Unit statement, the winning time appears nowhere, and the prize money is never mentioned. What is documented is a date — 10 September — and, beside it, the words 'provisional suspension'. The six-year count starts there.

Across three decades of watching the paper economy of road racing, I have found that the truth of a stadium race is usually clean and visible in the photo finish, while the truth of a road race hides in a form that should have carried a doctor's signature. In this case the signature existed. The doctor did not.

Context: the story larger than the result

Aga is a 32-year-old Ethiopian marathoner whose record was built by timing chips, not by an agent's brochure. Second at Berlin 2026 in 2:18:34, champion at the Tokyo Marathon 2026 in 2:20:40, and three second-place finishes at World Marathon Majors. That is a 2:18–2:20 career — a lifetime dream for 99 percent of the world's marathoners and an ordinary entry in Ethiopia's women's pool, where several athletes now sit under 2:16 and the world record belongs to the same country. Her exit does not move Ethiopian medal capacity by a single inch. This case is not about competition; it is about administration, which is exactly what makes it worth reading.

Core: two sanctions, one sum, one mislabelled substance

Start with the arithmetic. Two years for the presence violation, four for tampering — six total. The sum is itself a statement. A two-year presence sanction fits a Specified Substance finding without proven intent; four years is the Code's standard tampering sanction. The panel therefore rejected the no-significant-fault mitigation that would have pulled the presence sanction lower. The ledger does not lie: the three separate verification failures between the two and the four are the real story.

Then the technical point nearly every report got wrong. Media called methylprednisolone a prohibited steroid. It is a glucocorticoid — WADA Prohibited List class S9, not an anabolic steroid in class S1 — and S9 is prohibited in-competition only, by injection, oral or rectal route. A therapeutic knee injection given out of competition is entirely legal. The violation exists only if residues are present in competition.

The consequence is that the entire case turned on route and timing, not on steroid use. A road race's testing window opens at 23:59 the night before, so an injection given days earlier with proper records had a legitimate defence. Intra-articular methylprednisolone for knee synovitis is standard sports medicine in distance runners. That is the irony: the defence that could have worked was not destroyed by a document, but by a forged one.

The forgery chain has three independent failures. The 'doctor' who issued the prescription was a family member with no medical registration. The clinic named on the paper did not exist, or explicitly disowned the document. And the man claimed he had used an old prescription pad from a former workplace — a pad that was also disowned. One patient, one prescription, one clinic, one signature: four verification points, all empty.

And the four-year sanction came not from a document but from an interview, from statements given under AIU questioning. That detail matters, because language, interpretation and interview conditions are a recurring fault line in East African road-running cases. Where the paper is fake, the statement becomes the final evidence.

One thing no statement says but the timing implies: results and prize money. Standard practice voids the competition at which the sample was collected. The Chinese win, its appearance fee and any ranking points accrued afterwards are off the books.

Contrarian: six years for a substance with no proven benefit

Here is the angle nobody is writing. A glucocorticoid has no established endurance benefit. It reduces inflammation, dulls pain, and that is precisely why it is used on knees. A six-year ban has landed on a substance that does not make anyone faster — and four of those years landed on the paper used to conceal it. The weight of the sanction sits on the lie, not the drug. That distinction should have been the centre of the debate, and it is the one thing reporting erased.

The second angle is money. Chinese label races are a distinct income tier for East African marathoners: few races, high appearance fees, safe cash flow between Majors. Aga's post-2026 pattern was exactly that — selective Majors plus Asian label appearances. That same tier is now the AIU's highest-yield testing ground. The appearance-fee economy and the testing economy are colliding in the same race, and whoever earns there gets caught there. This is a structure, not a coincidence.

The third angle is the knee. This does not read like an acute March event. The attempt to manufacture a paper trail implies informal treatment long before it. A 32-year-old with no registered team physician, no TUE infrastructure and nobody to tell her the washout window will reach for the cheapest tool to mask pain. A forged prescription is a symptom of the empty chair where a medical officer should sit.

And the unasked question: did anyone advise her? Did an agent or manager see that document, accept it, pass it on? The statement names only the family member. The rest of the chain is dark, and that is the case's largest unresolved link.

Takeaway

Aga is 32. Six years puts her near 38 — at that age, in a pool that deep, with a doping record, selection is close to impossible. This is six years on paper and a career in practice. The question worth asking is where the real doctor will be next year when another East African runner arrives with a prescription bearing a clinic's name — because the problem is still standing exactly where it was, and only this case has closed.